iohexol has been researched along with Breast Neoplasms in 33 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
Breast Neoplasms: Tumors or cancer of the human BREAST.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In the present study, anionic linear globular dendrimer G2 is employed as a suitable carrier for delivery and AS1411 aptamer is exploited as the targeting agent to carry Iohexol specifically to the human breast cancer cells (MCF-7)." | 3.85 | AS1411 Aptamer-Anionic Linear Globular Dendrimer G2-Iohexol Selective Nano-Theranostics. ( Ardestani, MS; Bitarafan-Rajabi, A; Cohan, RA; Ghoreishi, SM; Mohammadzadeh, P, 2017) |
| "The patients with breast cancer diagnosed by sonographic guided biopsy without mammography were included for analysis." | 1.56 | Preoperative assessment of contrast-enhanced spectral mammography of diagnosed breast cancers after sonographic biopsy: Correlation to contrast-enhanced magnetic resonance imaging and 5-year postoperative follow-up. ( Cheung, YC; Juan, YH; Lin, YC; Lo, YF; Ueng, SH; Yeh, CH, 2020) |
| "Patients with a diagnosis of invasive breast cancer from January 2005 through December 2009 who underwent both DCE MR imaging and FDG PET/CT before treatment initiation were retrospectively identified." | 1.39 | Triple-negative and non-triple-negative invasive breast cancer: association between MR and fluorine 18 fluorodeoxyglucose PET imaging. ( Banfield, KS; Behr, SC; Bolouri, MS; Elias, SG; Hawkins, RA; Hylton, NM; Joe, BN; Suzuki, SA; Wisner, DJ, 2013) |
| " After the mask image had been taken, the contrast medium was administered using a dosage of 1ml/kg body weight at a rate of 4ml/s." | 1.37 | Evaluation of contrast-enhanced digital mammography. ( Bick, U; Diekmann, F; Diekmann, S; Fallenberg, EM; Fischer, T; Freyer, M; Pöllinger, A, 2011) |
| "The use of neoadjuvant chemotherapy for breast cancer is effective as postoperative adjuvant therapy, permits more lumpectomies, and can be used to study breast cancer biology." | 1.37 | Response rate to neoadjuvant chemotherapy measured on imaging predicts early recurrence and death in breast cancer patients with lymph node involvements. ( Kadowaki, M; Kazama, T; Miyazaki, M; Miyoshi, T; Nagashima, T; Nakatani, Y; Ohki, Y; Sakakibara, M; Suzuki, TH; Yokomizo, J, 2011) |
| "Thirty-three female patients with breast cancer and suspicion of recurrence underwent FDG-PET-CT and WB-MRI." | 1.35 | Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT. ( Bauerfeind, I; Baur-Melnyk, A; Haug, A; Heinemann, V; Reiser, MF; Schmidt, GP; Schoenberg, SO, 2008) |
| "A technique for demonstrating breast cancers, dual-energy contrast agent-enhanced digital subtraction mammography, was performed in 26 subjects with mammographic or clinical findings that warranted biopsy." | 1.32 | Dual-energy contrast-enhanced digital subtraction mammography: feasibility. ( Isaacs, PK; Larke, FJ; Lewin, JM; Vance, V, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (6.06) | 18.2507 |
| 2000's | 11 (33.33) | 29.6817 |
| 2010's | 19 (57.58) | 24.3611 |
| 2020's | 1 (3.03) | 2.80 |
| Authors | Studies |
|---|---|
| Amato, F | 1 |
| Bicchierai, G | 1 |
| Cirone, D | 1 |
| Depretto, C | 1 |
| Di Naro, F | 1 |
| Vanzi, E | 1 |
| Scaperrotta, G | 1 |
| Bartolotta, TV | 1 |
| Miele, V | 1 |
| Nori, J | 1 |
| Cheung, YC | 1 |
| Juan, YH | 1 |
| Lo, YF | 1 |
| Lin, YC | 1 |
| Yeh, CH | 1 |
| Ueng, SH | 1 |
| Mohammadzadeh, P | 1 |
| Cohan, RA | 1 |
| Ghoreishi, SM | 1 |
| Bitarafan-Rajabi, A | 1 |
| Ardestani, MS | 1 |
| Uhlig, J | 1 |
| Uhlig, A | 1 |
| Kunze, M | 1 |
| Beissbarth, T | 1 |
| Fischer, U | 1 |
| Lotz, J | 1 |
| Wienbeck, S | 1 |
| Phillips, J | 2 |
| Mihai, G | 1 |
| Hassonjee, SE | 1 |
| Raj, SD | 1 |
| Palmer, MR | 1 |
| Brook, A | 2 |
| Zhang, D | 1 |
| Kim, G | 1 |
| Cole, E | 1 |
| Mehta, T | 1 |
| Slanetz, P | 1 |
| Fishman, MDC | 1 |
| Karimova, E | 1 |
| Mehta, R | 1 |
| Lotfi, P | 1 |
| Resteghini, N | 1 |
| Raj, S | 1 |
| Dialani, V | 1 |
| Travieso-Aja, MDM | 1 |
| Maldonado-Saluzzi, D | 1 |
| Naranjo-Santana, P | 1 |
| Fernández-Ruiz, C | 1 |
| Severino-Rondón, W | 1 |
| Rodríguez Rodríguez, M | 1 |
| Vega Benítez, V | 1 |
| Pérez-Luzardo, O | 1 |
| Bolouri, MS | 1 |
| Elias, SG | 1 |
| Wisner, DJ | 1 |
| Behr, SC | 1 |
| Hawkins, RA | 1 |
| Suzuki, SA | 1 |
| Banfield, KS | 1 |
| Joe, BN | 1 |
| Hylton, NM | 1 |
| Badr, S | 1 |
| Laurent, N | 1 |
| Régis, C | 1 |
| Boulanger, L | 1 |
| Lemaille, S | 1 |
| Poncelet, E | 1 |
| Barra, FR | 1 |
| Ribeiro, AC | 1 |
| Mathieu, OD | 1 |
| Rodrigues, AC | 1 |
| Lobbes, MB | 1 |
| Lalji, U | 1 |
| Houwers, J | 1 |
| Nijssen, EC | 1 |
| Nelemans, PJ | 1 |
| van Roozendaal, L | 1 |
| Smidt, ML | 1 |
| Heuts, E | 1 |
| Wildberger, JE | 1 |
| Łuczyńska, E | 1 |
| Heinze-Paluchowska, S | 1 |
| Hendrick, E | 1 |
| Dyczek, S | 1 |
| Ryś, J | 1 |
| Herman, K | 1 |
| Blecharz, P | 1 |
| Jakubowicz, J | 1 |
| Sogani, J | 1 |
| Morris, EA | 2 |
| Kaplan, JB | 1 |
| D'Alessio, D | 1 |
| Goldman, D | 1 |
| Moskowitz, CS | 2 |
| Jochelson, MS | 2 |
| Tsigginou, A | 1 |
| Gkali, C | 1 |
| Chalazonitis, A | 1 |
| Feida, E | 1 |
| Vlachos, DE | 1 |
| Zagouri, F | 1 |
| Rellias, I | 1 |
| Dimitrakakis, C | 1 |
| Akashi-Tanaka, S | 1 |
| Shien, T | 1 |
| Tsukagoshi, S | 1 |
| Funabasama, S | 1 |
| Miyagawa, K | 1 |
| Terada, K | 1 |
| Yoshida, M | 1 |
| Hojo, T | 1 |
| Kinoshita, T | 1 |
| Moriyama, N | 1 |
| Raatschen, HJ | 1 |
| Fu, Y | 1 |
| Brasch, RC | 1 |
| Pietsch, H | 1 |
| Shames, DM | 1 |
| Yeh, BM | 1 |
| Veit-Haibach, P | 1 |
| Treyer, V | 1 |
| Strobel, K | 1 |
| Soyka, JD | 1 |
| Husmann, L | 1 |
| Schaefer, NG | 1 |
| Tschopp, A | 1 |
| Hany, TF | 1 |
| Ginat, DT | 1 |
| Sahler, LG | 1 |
| Siddall, KA | 1 |
| Diekmann, F | 3 |
| Freyer, M | 1 |
| Diekmann, S | 3 |
| Fallenberg, EM | 2 |
| Fischer, T | 1 |
| Bick, U | 3 |
| Pöllinger, A | 2 |
| Ellis, RL | 1 |
| Schmitzberger, FF | 1 |
| Lawaczeck, R | 1 |
| Hemmendorff, M | 1 |
| Moa, E | 1 |
| Danielsson, M | 1 |
| Engelken, FJ | 1 |
| Nagashima, T | 1 |
| Sakakibara, M | 1 |
| Kadowaki, M | 1 |
| Suzuki, TH | 1 |
| Yokomizo, J | 1 |
| Ohki, Y | 1 |
| Miyoshi, T | 1 |
| Kazama, T | 1 |
| Nakatani, Y | 1 |
| Miyazaki, M | 1 |
| Dershaw, DD | 1 |
| Sung, JS | 1 |
| Heerdt, AS | 1 |
| Thornton, C | 1 |
| Ferrara, J | 1 |
| Taupitz, M | 1 |
| Winzer, KJ | 1 |
| Hüttner, C | 1 |
| Muller, S | 2 |
| Jeunehomme, F | 1 |
| Hamm, B | 1 |
| Jong, RA | 1 |
| Yaffe, MJ | 1 |
| Skarpathiotakis, M | 1 |
| Shumak, RS | 1 |
| Danjoux, NM | 1 |
| Gunesekara, A | 1 |
| Plewes, DB | 1 |
| Lewin, JM | 1 |
| Isaacs, PK | 1 |
| Vance, V | 1 |
| Larke, FJ | 1 |
| Patel, A | 1 |
| Pain, SJ | 1 |
| Britton, P | 1 |
| Sinnatamby, R | 1 |
| Warren, R | 1 |
| Bobrow, L | 1 |
| Barber, RW | 1 |
| Peters, AM | 1 |
| Purushotham, AD | 1 |
| Vetshev, PS | 1 |
| Ternovo, SK | 1 |
| Abduraimov, AB | 1 |
| Arablinskiĭ, AV | 1 |
| Shekhter, AI | 1 |
| Dromain, C | 1 |
| Balleyguier, C | 1 |
| Mathieu, MC | 1 |
| Rochard, F | 1 |
| Opolon, P | 1 |
| Sigal, R | 1 |
| Rissanen, T | 1 |
| Reinikainen, H | 1 |
| Apaja-Sarkkinen, M | 1 |
| Schmidt, GP | 1 |
| Baur-Melnyk, A | 1 |
| Haug, A | 1 |
| Heinemann, V | 1 |
| Bauerfeind, I | 1 |
| Reiser, MF | 1 |
| Schoenberg, SO | 1 |
| Zeman, RK | 1 |
| Zeiberg, AS | 1 |
| Davros, WJ | 1 |
| Ascher, SM | 1 |
| Cooper, CJ | 1 |
| Weltman, DI | 1 |
| Patt, R | 1 |
| Garra, BS | 1 |
| Griego, DL | 1 |
| Silverman, PM | 1 |
| Mori, O | 1 |
| Miyasato, M | 1 |
| Karashima, T | 1 |
| Hashimoto, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of Contrast-enhanced Mammography and Contrast-enhanced Breast Tomosynthesis: Comparison to Contrast-enhanced Breast MRI- A Pilot Study[NCT01433640] | 30 participants (Actual) | Observational | 2011-07-31 | Completed | |||
| Diagnostic Utility of MRI in Female Patients With Nipple Discharge: A Prospective Trial[NCT02818946] | 30 participants (Actual) | Interventional | 2016-07-31 | Terminated (stopped due to low enrollment) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for iohexol and Breast Neoplasms
| Article | Year |
|---|---|
Comparison between breast MRI and contrast-enhanced spectral mammography.
Topics: Breast Diseases; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltratin | 2015 |
Radioguided occult lesion localisation (ROLL) and sentinel node biopsy for impalpable invasive breast cancer.
Topics: Aged; Breast Neoplasms; Female; Humans; Iohexol; Lymphatic Metastasis; Middle Aged; Palpation; Radio | 2004 |
31 other studies available for iohexol and Breast Neoplasms
| Article | Year |
|---|---|
Preoperative loco-regional staging of invasive lobular carcinoma with contrast-enhanced digital mammography (CEDM).
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Lobular; Contrast Media; Female; Humans; Iohexol; Mammogra | 2019 |
Preoperative assessment of contrast-enhanced spectral mammography of diagnosed breast cancers after sonographic biopsy: Correlation to contrast-enhanced magnetic resonance imaging and 5-year postoperative follow-up.
Topics: Adult; Aged; Breast Neoplasms; Contrast Media; Feasibility Studies; Female; Follow-Up Studies; Gadol | 2020 |
AS1411 Aptamer-Anionic Linear Globular Dendrimer G2-Iohexol Selective Nano-Theranostics.
Topics: Breast Neoplasms; Dendrimers; Drug Delivery Systems; Female; HEK293 Cells; Humans; Iohexol; MCF-7 Ce | 2017 |
Novel Breast Imaging and Machine Learning: Predicting Breast Lesion Malignancy at Cone-Beam CT Using Machine Learning Techniques.
Topics: Breast Neoplasms; Cone-Beam Computed Tomography; Contrast Media; Female; Humans; Iohexol; Machine Le | 2018 |
Comparative Dose of Contrast-Enhanced Spectral Mammography (CESM), Digital Mammography, and Digital Breast Tomosynthesis.
Topics: Adult; Aged; Breast Neoplasms; Contrast Media; Female; Humans; Iohexol; Mammography; Middle Aged; Ph | 2018 |
Comparison of Contrast-Enhanced Mammography With Conventional Digital Mammography in Breast Cancer Screening: A Pilot Study.
Topics: Adult; Aged; Breast Neoplasms; Contrast Media; Early Detection of Cancer; Female; Humans; Iohexol; M | 2019 |
Diagnostic performance of contrast-enhanced dual-energy spectral mammography (CESM): a retrospective study involving 644 breast lesions.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Breast Neoplasms; Contrast Media; Diagnosis, Differential; F | 2019 |
Triple-negative and non-triple-negative invasive breast cancer: association between MR and fluorine 18 fluorodeoxyglucose PET imaging.
Topics: Breast Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Image Int | 2013 |
Dual-energy contrast-enhanced digital mammography in routine clinical practice in 2013.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Contrast Media; Diagnosis, Differential; F | 2014 |
Dual-energy contrast-enhanced digital mammography: examination protocol.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Contrast Media; Female; Humans; Iohexol; Mammography; R | 2014 |
Contrast-enhanced spectral mammography in patients referred from the breast cancer screening programme.
Topics: Aged; Breast; Breast Neoplasms; Contrast Media; Diagnosis, Differential; Early Detection of Cancer; | 2014 |
Comparison of Background Parenchymal Enhancement at Contrast-enhanced Spectral Mammography and Breast MR Imaging.
Topics: Adult; Aged; Breast Density; Breast Neoplasms; Contrast Media; Female; Humans; Image Enhancement; Im | 2017 |
Adding the power of iodinated contrast media to the credibility of mammography in breast cancer diagnosis.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Breast Neoplasms; Contrast Media; Diagnosis, Differential; E | 2016 |
Whole-breast volume perfusion images using 256-row multislice computed tomography: visualization of lesions with ductal spread.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Cont | 2009 |
In vivo monitoring of angiogenesis inhibitory treatment effects by dynamic contrast-enhanced computed tomography in a xenograft tumor model.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevaciz | 2009 |
Feasibility of integrated CT-liver perfusion in routine FDG-PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Co | 2010 |
External herniation of a subareolar intraductal papilloma: a rare, yet beneficial, complication of conventional ductography.
Topics: Breast Neoplasms; Contrast Media; Exudates and Transudates; Female; Hernia; Humans; Iohexol; Mammary | 2009 |
Evaluation of contrast-enhanced digital mammography.
Topics: Adult; Area Under Curve; Breast Neoplasms; Chi-Square Distribution; Contrast Media; Diagnosis, Diffe | 2011 |
Sonographic confirmation of a mammographically detected breast lesion.
Topics: Adult; Breast Neoplasms; Contrast Media; Female; Fibroadenoma; Humans; Iohexol; Mammography; Ultraso | 2011 |
Development of low-dose photon-counting contrast-enhanced tomosynthesis with spectral imaging.
Topics: Aged; Biopsy; Breast Neoplasms; Contrast Media; Feasibility Studies; Female; Gadolinium DTPA; Humans | 2011 |
Response rate to neoadjuvant chemotherapy measured on imaging predicts early recurrence and death in breast cancer patients with lymph node involvements.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biopsy; Breast Neoplasms; Chemo | 2011 |
Bilateral contrast-enhanced dual-energy digital mammography: feasibility and comparison with conventional digital mammography and MR imaging in women with known breast carcinoma.
Topics: Adult; Aged; Breast Neoplasms; Contrast Media; Feasibility Studies; Female; Humans; Iohexol; Magneti | 2013 |
Use of iodine-based contrast media in digital full-field mammography--initial experience.
Topics: Breast Neoplasms; Contrast Media; Female; Humans; Iohexol; Mammography; Phantoms, Imaging; Radiation | 2003 |
Contrast-enhanced digital mammography: initial clinical experience.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Contrast Media; Female; Humans; Injections | 2003 |
Dual-energy contrast-enhanced digital subtraction mammography: feasibility.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma; Contrast Media; Feasibility Studies; Fe | 2003 |
[Multispiral computed tomography in diagnosis of tumors of the mammary gland].
Topics: Adult; Aged; Breast Neoplasms; Contrast Media; Diagnosis, Differential; Female; Fibroadenoma; Fibroc | 2005 |
Evaluation of tumor angiogenesis of breast carcinoma using contrast-enhanced digital mammography.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Contrast Media; Humans; Iohexol; Mammography; Midd | 2006 |
Breast sonography in localizing the cause of nipple discharge: comparison with galactography in 52 patients.
Topics: Adult; Aged; Aged, 80 and over; Breast Diseases; Breast Neoplasms; Contrast Media; Diagnosis, Differ | 2007 |
Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT.
Topics: Adult; Aged; Breast Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Interpr | 2008 |
Routine helical CT of the abdomen: image quality considerations.
Topics: Abdominal Neoplasms; Adult; Aged; Aged, 80 and over; Algorithms; Artifacts; Breast Neoplasms; Female | 1993 |
Immunobead and density gradient purification of Paget cells: in vitro studies of proliferation.
Topics: Aged; Aged, 80 and over; Breast Neoplasms; Carcinoembryonic Antigen; Cell Count; Contrast Media; Fem | 1998 |